ATR Share Price | AptarGroup, Inc. Stock Analysis & Recommendation

Q: How big is AptarGroup, Inc.?

Market Cap: As of Jun 18, AptarGroup, Inc. has a market capitalization of 10,542.31 million, classifying it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, AptarGroup, Inc. reported net sales of 3,554.74 million and a net profit of 369.90 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2,471.89 million and total assets of 4,432.28 million.

Q: What does AptarGroup, Inc. do?

Overview: AptarGroup, Inc. is a provider of a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food, and beverage markets, operating in the packaging industry within the mid-cap market.Financial Snapshot: Most recent Net Sales: 887 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 79 Million (Quarterly Results - Mar 2025) Market-cap: USD 10,542.31 Million (Mid Cap)Key Metrics: P/E: 28.00 Dividend Yield: 84.34% Debt Equity: 0.34 Return on Equity: 15.02% Price to Book: 4.15Contact Details: Address: 265 Exchange Dr Ste 100, CRYSTAL LAKE IL: 60014-6230 Tel: 1 815 4770424 Fax: 1 815 4770481 Website: https://www.aptar.com/

Q: Is AptarGroup, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for AptarGroup, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength indicated by the weekly MACD and Bollinger Bands both showing bearish signals. The daily moving averages also confirm a bearish outlook. While the monthly RSI is bullish, it contrasts with the overall bearish sentiment from the other indicators. Additionally, the company has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -14.39% versus the S&P 500's 12.22%.

Q: Is AptarGroup, Inc. overvalued or undervalued?

As of 17 October 2025, AptarGroup, Inc. has moved from expensive to attractive, indicating a significant improvement in its valuation outlook. The company appears undervalued based on its current metrics, with a P/E ratio of 28, an EV to EBITDA of 15.02, and a PEG ratio of 3.61. In comparison to its peers, AptarGroup's P/E ratio is lower than Ball Corp.'s 38.35 and Avery Dennison Corp.'s 28.96, suggesting that it is trading at a discount relative to these competitors.Despite recent stock performance lagging behind the S&P 500, with a year-to-date return of -17.67% compared to the index's 13.30%, the attractive valuation grade and favorable ratios indicate that AptarGroup may present a compelling investment opportunity at its current price of 129.34.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

104.04 k

Shareholding (Dec 2025)

FII

14.36%

Held by 184 FIIs

DII

42.67%

Held by 50 DIIs

Promoter

0.09%

How big is AptarGroup, Inc.?

22-Jun-2025

As of Jun 18, AptarGroup, Inc. has a market capitalization of $10.54 billion, with net sales of $3.55 billion and a net profit of $369.90 million over the last four quarters.

View full answer

What does AptarGroup, Inc. do?

22-Jun-2025

AptarGroup, Inc. provides packaging, dispensing, and sealing solutions for various markets, including beauty, healthcare, and food. As of March 2025, it reported net sales of $887 million and a market cap of approximately $10.54 billion.

View full answer

Who are in the management team of AptarGroup, Inc.?

22-Jun-2025

As of March 2022, the management team of AptarGroup, Inc. includes Mr. George Fotiades (Independent Non-Executive Chairman), Mr. Stephan Tanda (President and CEO), and five Independent Directors: Ms. Giovanna Kampouri Monnas, Mr. Andreas Kramvis, Ms. Isabel Marey-Semper, and Ms. Maritza Montiel.

View full answer

Is AptarGroup, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, AptarGroup, Inc. shows a bearish trend with moderate strength from indicators like the MACD and Bollinger Bands, despite a contrasting bullish monthly RSI, and has underperformed the S&P 500 with a year-to-date return of -14.39%.

View full answer

Is AptarGroup, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, AptarGroup, Inc. is considered an attractive investment opportunity due to its undervalued metrics, including a P/E ratio of 28, lower than its peers, despite a year-to-date stock performance lagging behind the S&P 500.

View full answer

Compare AptarGroup, Inc. with Similar Stocks

WestRock Co.Crown Holdings, Inc.Owens Corning

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 11.22

Poor long term growth as Net Sales has grown by an annual rate of 5.27% and Operating profit at 8.04% over the last 5 years

Flat results in Jun 25

With ROCE of 15.05%, it has a very expensive valuation with a 3.43 Enterprise value to Capital Employed

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Packaging

Market cap

USD 8,889 Million (Small Cap)

P/E

22.00

Industry P/E

Dividend Yield

1.39%

Debt Equity

0.40

Return on Equity

15.04%

Price to Book

3.33

Revenue and Profits:

Net Sales:

963 Million

(Quarterly Results - Dec 2025)

Net Profit:

74 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.5%

6 Months

-3.82%

1 Year

-14.53%

2 Years

-11.99%

3 Years

11.37%

4 Years

7.32%

5 Years

-11.69%

AptarGroup, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.22%

EBIT Growth (5y)

5.73%

EBIT to Interest (avg)

11.22

Debt to EBITDA (avg)

1.44

Net Debt to Equity (avg)

0.34

Sales to Capital Employed (avg)

0.99

Tax Ratio

21.54%

Dividend Payout Ratio

31.11%

Pledged Shares

Institutional Holding

99.61%

ROCE (avg)

13.70%

ROE (avg)

13.59%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.33

EV to EBIT

19.48

EV to EBITDA

12.47

EV to Capital Employed

2.66

EV to Sales

2.64

PEG Ratio

4.06

Dividend Yield

1.39%

ROCE (Latest)

13.68%

ROE (Latest)

15.04%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 116 Schemes (42.85%)

Foreign Institutions

Held by 184 Foreign Institutions (14.36%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.17% vs -0.51% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -41.86% vs 14.41% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "962.70",
          "val2": "961.10",
          "chgp": "0.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "187.30",
          "val2": "214.30",
          "chgp": "-12.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.00",
          "val2": "13.50",
          "chgp": "25.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.30",
          "val2": "-3.10",
          "chgp": "-70.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "74.30",
          "val2": "127.80",
          "chgp": "-41.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.00%",
          "val2": "144.70%",
          "chgp": "-2.97%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.42% vs 2.74% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.89% vs 31.67% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,777.20",
          "val2": "3,582.90",
          "chgp": "5.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "799.70",
          "val2": "776.70",
          "chgp": "2.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "52.70",
          "val2": "43.90",
          "chgp": "20.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-12.10",
          "val2": "-14.90",
          "chgp": "18.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "392.50",
          "val2": "374.20",
          "chgp": "4.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.60%",
          "val2": "143.20%",
          "chgp": "-0.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

962.70

961.10

0.17%

Operating Profit (PBDIT) excl Other Income

187.30

214.30

-12.60%

Interest

17.00

13.50

25.93%

Exceptional Items

-5.30

-3.10

-70.97%

Consolidate Net Profit

74.30

127.80

-41.86%

Operating Profit Margin (Excl OI)

115.00%

144.70%

-2.97%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.17% vs -0.51% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -41.86% vs 14.41% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,777.20

3,582.90

5.42%

Operating Profit (PBDIT) excl Other Income

799.70

776.70

2.96%

Interest

52.70

43.90

20.05%

Exceptional Items

-12.10

-14.90

18.79%

Consolidate Net Profit

392.50

374.20

4.89%

Operating Profit Margin (Excl OI)

135.60%

143.20%

-0.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 5.42% vs 2.74% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 4.89% vs 31.67% in Dec 2024

All Annual Results

Company CV

About AptarGroup, Inc.

AptarGroup, Inc.

Packaging

AptarGroup, Inc. is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America. The Company operates through three segments: Beauty + Home, Pharma and Food + Beverage. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps, closures, aerosol valves and elastomeric primary packaging components. Its elastomeric components also include pre filled syringe components, such as plungers, needle shields, tip caps and cartridges, as well as dropper bulbs and syringe plungers. Its Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories and sealing solutions to the personal care and home care markets, and pumps and decorative components to the beauty market.

Company Coordinates

Company Details

265 Exchange Dr Ste 100 , CRYSTAL LAKE IL : 60014-6230

Tel: 1 815 4770424

https://www.aptar.com/

Registrar Details